XML 47 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Note 21 - Revision of Previously Issued Unaudited Quarterly Information
12 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Error Correction [Text Block]

21.    Revision of Previously Issued Unaudited Quarterly Information

 

The Condensed Consolidated Statements of Cash Flows for the interim periods ended  March 31, 2023,  June 30, 2023, December 31, 2023, March 31, 2024, and June 30, 2024 have been revised to correct for prior period errors as discussed in Note 2, Summary of Significant Accounting Policies. The effect on the Condensed Consolidated Statement of Cash Flows for each affected period is as follows (in thousands):

 

  

Nine months ended June 30, 2023

 

(unaudited)

 

As Reported

  

Adjustments

  

As Revised

 

Cash flows from operating activities

            

Accrued compensation and tax withholdings

 $(15,830) $(1,852) $(17,682)

Other current assets and liabilities

  (36,578)  2,634   (33,944)

Net cash used in operating activities

 $(22,422) $782  $(21,640)
             

Cash flows from financing activities

            

Proceeds from issuance of common stock

 $-  $1,852  $1,852 

Net cash used in financing activities

 $(677,221) $1,852  $(675,369)
             

Effects of exchange rate changes on cash and cash equivalents

 $65,610  $(2,634) $62,976 
             

Supplemental disclosures:

            

Purchases of property, plant and equipment included in accounts payable and accrued expenses

 $-  $2,898  $2,898 

 

  

Six months ended March 31, 2023

 

(unaudited)

 

As Reported

  

Adjustments

  

As Revised

 

Cash flows from operating activities

            

Accrued compensation and tax withholdings

 $(21,797) $(1,852) $(23,649)

Net cash used in operating activities

 $(39,170) $(1,852) $(41,022)
             

Cash flows from financing activities

            

Proceeds from issuance of common stock

 $-  $1,852  $1,852 

Net cash used in financing activities

 $(505,136) $1,852  $(503,284)
             

Supplemental disclosures:

            

Purchases of property, plant and equipment included in accounts payable and accrued expenses

 $-  $3,040  $3,040 

 

 

  

Nine months ended June 30, 2024

 

(unaudited)

 

As Reported

  

Adjustments

  

As Revised

 

Cash flows from operating activities

            

Inventories

 $11,433  $2,674  $14,107 

Other assets and liabilities

  7,484   (7,101)  383 

Net cash provided by operating activities

 $36,578  $(4,427) $32,151 
             

Cash flows from investing activities

            

Purchase of property, plant and equipment

 $(25,339) $(2,674) $(28,013)

Net cash provided by investing activities

 $29,406  $(2,674) $26,732 
             

Effects of exchange rate changes on cash and cash equivalents

 $8,495  $7,101  $15,596 
             

Supplemental disclosures:

            

Purchases of property, plant and equipment included in accounts payable and accrued expenses

 $2,203  $372  $2,575 

 

  

Six months ended March 31, 2024

 

(unaudited)

 

As Reported

  

Adjustments

  

As Revised

 

Cash flows from operating activities

            

Non-cash write-offs of assets

 $6,966  $533  $7,499 

Inventories

  7,975   263   8,238 

Accrued compensation and tax withholdings

  (6,153)  (1,678)  (7,831)

Other assets and liabilities

  12,913   (11,534)  1,379 

Net cash provided by operating activities

 $34,787  $(12,416) $22,371 
             

Cash flows from investing activities

            

Purchase of property, plant and equipment

 $(18,746) $(796) $(19,542)

Net cash used in investing activities

 $(172,213) $(796) $(173,009)
             

Cash flows from financing activities

            

Proceeds from issuance of common stock

 $-  $1,678  $1,678 

Net cash used in financing activities

 $(187,220) $1,678  $(185,542)
             

Effects of exchange rate changes on cash and cash equivalents

 $4,721  $11,534  $16,255 
             

Supplemental disclosures:

            

Purchases of property, plant and equipment included in accounts payable and accrued expenses

 $-  $2,270  $2,270 

 

 

  

Three months ended December 31, 2023

 

(unaudited)

 

As Reported

  

Adjustments

  

As Revised

 

Cash flows from operating activities

            

Inventories

 $4,542  $387  $4,929 

Accounts payable

  3,457   (1,015)  2,442 

Other assets and liabilities

  15,957   (12,047)  3,910 

Net cash provided by operating activities

 $26,431  $(12,675) $13,756 
             

Cash flows from investing activities

            

Purchase of property, plant and equipment

 $(11,919) $628  $(11,291)

Net cash provided by investing activities

 $98,397  $628  $99,025 
             

Effects of exchange rate changes on cash and cash equivalents

 $12,501  $12,047  $24,548 
             

Supplemental disclosures:

            

Purchases of property, plant and equipment included in accounts payable and accrued expenses

 $-  $2,164  $2,164